The GLP-1, GIP, and glucagon mechanism is complex
At 13 weeks, only two participants remained in each arm, with observed mean weight loss of 6.8% for those receiving tesomet, compared to 0.8% for those on placebo (144)
Working with your physician to adjust antihypertensive doses as weight drops and metabolic health improves represents one of the most satisfying aspects of this treatment approach
The pricing is transparent, the delivery is fast and the onboarding is as close to frictionless as any platform in this space
Issue Section License Copyright (c) 2025 Canadian Diabetes & Endocrinology Today This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
Before we discuss how to inject semaglutide, lets go over what this medication is used for